Oruka Therapeutics (ORKA) Cash from Investing Activities Growth (5y) (2015 - 2026)
Oruka Therapeutics (ORKA) Cash from Investing Activities Growth (5y) (2015 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,621.14 Bn | 66,620.85 Bn | - |
| 2 | Nanobiotix | 1,915.18 Bn | 1,915.11 Bn | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - |
| 4 | BeOne Medicines | 471.27 Bn | 466.48 Bn | 1.35 Bn |
| 5 | Vertex Pharmaceuticals | 121.81 Bn | 114.57 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 69.58 Bn | 60.82 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.72 Bn | 62.72 Bn | - |
| 8 | Argenx Se | 55.51 Bn | 50.33 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.35 Bn | 37.35 Bn | - |
| 10 | Oruka Therapeutics | 949.58 Mn | 118.43 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -374.53% |
| Dec 31, 2025 | -342.37% |
| Jun 30, 2025 | 338.54% |
| Mar 31, 2025 | 577.66% |
| Dec 31, 2024 | -1,005.31% |
| Mar 31, 2022 | -14.88% |
| Dec 31, 2021 | -14.90% |
| Sep 30, 2021 | 64.68% |
| Jun 30, 2021 | 73.31% |
| Mar 31, 2021 | 74.15% |
| Dec 31, 2020 | -45.41% |
| Jun 30, 2020 | 9.71% |
| Mar 31, 2020 | -8.45% |
| Dec 31, 2019 | 32.24% |
| Sep 30, 2018 | 22.88% |
| Mar 31, 2018 | 220.99% |
| Dec 31, 2016 | 262.92% |
| Sep 30, 2016 | -380.07% |
| Dec 31, 2015 | -14.96% |